BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 3930830)

  • 1. [Interferons--biologic principles and clinical uses].
    Jacobsen H; Kirchner H
    Klin Padiatr; 1985; 197(4):263-7. PubMed ID: 3930830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The interferon system. A review of biological principles and clinical uses].
    Schneider FJ
    Z Gesamte Inn Med; 1986 Nov; 41(22):613-8. PubMed ID: 2436387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Interferon--properties and action].
    Zamorska I; Kozłowski M
    Wiad Lek; 1989 Oct 1-Nov 1; 42(19-21):1086-91. PubMed ID: 2517808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inborn errors of interferon (IFN)-mediated immunity in humans: insights into the respective roles of IFN-alpha/beta, IFN-gamma, and IFN-lambda in host defense.
    Zhang SY; Boisson-Dupuis S; Chapgier A; Yang K; Bustamante J; Puel A; Picard C; Abel L; Jouanguy E; Casanova JL
    Immunol Rev; 2008 Dec; 226():29-40. PubMed ID: 19161414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Interferons: physiology, pharmacology and pharmacotherapeutic perspectives].
    Billiau A
    J Pharmacol; 1983; 14 Suppl 3():105-16. PubMed ID: 6200731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferons, interferon-like cytokines, and their receptors.
    Pestka S; Krause CD; Walter MR
    Immunol Rev; 2004 Dec; 202():8-32. PubMed ID: 15546383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Independent evolution of antiviral and growth-modulating activities of interferon.
    Carter WA; Swartz H; Gillespie DH
    J Biol Response Mod; 1985 Oct; 4(5):447-59. PubMed ID: 2416881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Current status of interferon therapy].
    Dittrich C
    Wien Med Wochenschr; 1986 Apr; 136(7-8):163-72. PubMed ID: 2425497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts).
    Gattoni A; Parlato A; Vangieri B; Bresciani M; Derna R
    Clin Ter; 2006; 157(4):377-86. PubMed ID: 17051976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Interferon in the treatment of viral, neoplastic and immunologic diseases].
    Inglot AD
    Patol Pol; 1984; 35(3):245-61. PubMed ID: 6085509
    [No Abstract]   [Full Text] [Related]  

  • 11. Human interferons alpha, beta and omega.
    Bekisz J; Schmeisser H; Hernandez J; Goldman ND; Zoon KC
    Growth Factors; 2004 Dec; 22(4):243-51. PubMed ID: 15621727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type I interferons in the pathogenesis and treatment of canine diseases.
    Klotz D; Baumgärtner W; Gerhauser I
    Vet Immunol Immunopathol; 2017 Sep; 191():80-93. PubMed ID: 28895871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Interferon--a new therapeutic principle].
    Micksche M
    Wien Med Wochenschr; 1993; 143(16-17):408-12. PubMed ID: 8273362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current view on the perspectives of interferon therapy.
    Borecký L
    Acta Virol; 1986 Mar; 30(2):161-9. PubMed ID: 2425613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic antiproliferative effects of human recombinant alpha 54- or beta ser-interferon with gamma-interferon on human cell lines of various histogenesis.
    Schiller JH; Groveman DS; Schmid SM; Willson JK; Cummings KB; Borden EC
    Cancer Res; 1986 Feb; 46(2):483-8. PubMed ID: 2416427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential antiproliferative activities of IFNs alpha, beta and gamma: kinetics of establishment of their antiproliferative effects and the rapid development of resistance to IFNs alpha and beta.
    Fleischmann CM; Fleischmann WR
    J Biol Regul Homeost Agents; 1988; 2(4):173-85. PubMed ID: 3150645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of hyperthermia on the antiproliferative activities of murine alpha-, beta-, and gamma-interferon: differential enhancement of murine gamma-interferon.
    Fleischmann WR; Fleischmann CM; Gindhart TD
    Cancer Res; 1986 Jan; 46(1):8-13. PubMed ID: 2998611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Types I and II interferons upregulate the costimulatory CD80 molecule in monocytes via interferon regulatory factor-1.
    Bauvois B; Nguyen J; Tang R; Billard C; Kolb JP
    Biochem Pharmacol; 2009 Sep; 78(5):514-22. PubMed ID: 19433065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophage colony stimulating factor (CSF-1) blocks the myeloid suppressive but not the antiviral or antiproliferative activities of murine alpha, beta, and gamma interferons in vitro.
    Koren S; Klimpel GR; Fleischmann WR
    J Biol Response Mod; 1986 Dec; 5(6):571-80. PubMed ID: 2432191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The interferon system with special reference to gamma-interferons].
    Kirchner H
    Dtsch Med Wochenschr; 1986 Jan; 111(2):64-70. PubMed ID: 2416525
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.